Moreover, the vast majority of reports have shown that upregulation of CD95L by cancer cells is an adverse prognostic marker for many solid tumours [40], and the elimination of CD95 or CD95L in cancer cells induces "death induced by CD95 or CD95L" [45]. This evidence concerns the gene FAS and cancer.